Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117


Addressing clinical trials: can the multidisciplinary Tumor Board improve participation? A study from an academic women's cancer program.

Kuroki L, Stuckey A, Hirway P, Raker CA, Bandera CA, DiSilvestro PA, Granai CO, Legare RD, Sakr BJ, Dizon DS.

Gynecol Oncol. 2010 Mar;116(3):295-300. doi: 10.1016/j.ygyno.2009.12.005. Epub 2009 Dec 29.


Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study.

Brooks SE, Carter RL, Plaxe SC, Basen-Engquist KM, Rodriguez M, Kauderer J, Walker JL, Myers TK, Drake JG, Havrilesky LJ, Van Le L, Landrum LM, Brown CL.

Gynecol Oncol. 2015 Jul;138(1):101-8. doi: 10.1016/j.ygyno.2015.04.033. Epub 2015 Apr 30.


Factors associated with clinical trial screening failures in gynecologic oncology.

Manders DB, Paulsen A, Richardson DL, Kehoe SM, Miller DS, Lea JS.

Gynecol Oncol. 2014 Sep;134(3):450-4. doi: 10.1016/j.ygyno.2014.06.023. Epub 2014 Jun 30.


A novel clinical trial recruitment strategy for women's cancer.

Rimel BJ, Lester J, Sabacan L, Park D, Bresee C, Dang C, Karlan B.

Gynecol Oncol. 2015 Aug;138(2):445-8. doi: 10.1016/j.ygyno.2015.05.008. Epub 2015 May 20.


Willingness of gynecologic cancer patients to participate in clinical trials.

Mathews C, Restivo A, Raker C, Weitzen S, Disilvestro P.

Gynecol Oncol. 2009 Jan;112(1):161-5. doi: 10.1016/j.ygyno.2008.09.003. Epub 2008 Oct 25.


Involving American Indians and medically underserved rural populations in cancer clinical trials.

Guadagnolo BA, Petereit DG, Helbig P, Koop D, Kussman P, Fox Dunn E, Patnaik A.

Clin Trials. 2009 Dec;6(6):610-7. doi: 10.1177/1740774509348526. Epub 2009 Nov 23.


Incentives and enablers to improve adherence in tuberculosis.

Lutge EE, Wiysonge CS, Knight SE, Sinclair D, Volmink J.

Cochrane Database Syst Rev. 2015 Sep 3;(9):CD007952. doi: 10.1002/14651858.CD007952.pub3. Review.


Organizational and physician factors associated with patient enrollment in cancer clinical trials.

Jacobs SR, Weiner BJ, Reeve BB, Weinberger M, Minasian LM, Good MJ.

Clin Trials. 2014 Oct;11(5):565-75. doi: 10.1177/1740774514536000. Epub 2014 Jun 5.


The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.

Denicoff AM, McCaskill-Stevens W, Grubbs SS, Bruinooge SS, Comis RL, Devine P, Dilts DM, Duff ME, Ford JG, Joffe S, Schapira L, Weinfurt KP, Michaels M, Raghavan D, Richmond ES, Zon R, Albrecht TL, Bookman MA, Dowlati A, Enos RA, Fouad MN, Good M, Hicks WJ, Loehrer PJ Sr, Lyss AP, Wolff SN, Wujcik DM, Meropol NJ.

J Oncol Pract. 2013 Nov;9(6):267-76. doi: 10.1200/JOP.2013.001119. Epub 2013 Oct 15.


Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled Trials.

Logan JK, Tang C, Liao Z, Lee JJ, Heymach JV, Swisher SG, Welsh JW, Zhang J, Lin SH, Gomez DR.

Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):770-777. doi: 10.1016/j.ijrobp.2016.11.035. Epub 2016 Nov 27.


Eligibility determination for clinical trials: development of a case review process at a chiropractic research center.

Vining RD, Salsbury SA, Pohlman KA.

Trials. 2014 Oct 24;15:406. doi: 10.1186/1745-6215-15-406.


Removing barriers to participation in clinical trials, a conceptual framework and retrospective chart review study.

Kanarek NF, Kanarek MS, Olatoye D, Carducci MA.

Trials. 2012 Dec 10;13:237. doi: 10.1186/1745-6215-13-237.


Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.

Lara PN Jr, Higdon R, Lim N, Kwan K, Tanaka M, Lau DH, Wun T, Welborn J, Meyers FJ, Christensen S, O'Donnell R, Richman C, Scudder SA, Tuscano J, Gandara DR, Lam KS.

J Clin Oncol. 2001 Mar 15;19(6):1728-33.


Low Enrollment of Adolescents and Young Adults Onto Cancer Trials: Insights From the Community Clinical Oncology Program.

Roth ME, O'Mara AM, Seibel NL, Dickens DS, Langevin AM, Pollock BH, Freyer DR.

J Oncol Pract. 2016 Apr;12(4):e388-95. doi: 10.1200/JOP.2015.009084. Epub 2016 Mar 29.


Achieving high cancer control trial enrollment in the community setting: an analysis of the Community Clinical Oncology Program.

Jacobs SR, Weiner BJ, Minasian LM, Good MJ.

Contemp Clin Trials. 2013 Mar;34(2):320-5. doi: 10.1016/j.cct.2012.12.008. Epub 2013 Jan 5.


[Study of the factors motivating refusal of women to participate to a randomized clinical trial in gynecological surgery. Retrospective observational bicentric study].

Nguyen-Xuan HT, Thiollier G, Ruault O, Fauconnier A, Lucot JP, Bader G.

J Gynecol Obstet Biol Reprod (Paris). 2016 Nov;45(9):1054-1059. doi: 10.1016/j.jgyn.2016.03.001. Epub 2016 Apr 22. French.


A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).

Javid SH, Unger JM, Gralow JR, Moinpour CM, Wozniak AJ, Goodwin JW, Lara PN Jr, Williams PA, Hutchins LF, Gotay CC, Albain KS.

Oncologist. 2012;17(9):1180-90. Epub 2012 Jun 20.


Increasing minority patient participation in cancer clinical trials using oncology nurse navigation.

Holmes DR, Major J, Lyonga DE, Alleyne RS, Clayton SM.

Am J Surg. 2012 Apr;203(4):415-22. doi: 10.1016/j.amjsurg.2011.02.005. Epub 2011 Oct 13.


Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study.

Campbell MK, Snowdon C, Francis D, Elbourne D, McDonald AM, Knight R, Entwistle V, Garcia J, Roberts I, Grant A, Grant A; STEPS group.

Health Technol Assess. 2007 Nov;11(48):iii, ix-105. Review.


Involving South Asian patients in clinical trials.

Hussain-Gambles M, Leese B, Atkin K, Brown J, Mason S, Tovey P.

Health Technol Assess. 2004 Oct;8(42):iii, 1-109. Review.

Supplemental Content

Support Center